Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J I Weitz

Showing results (11-20 of 136) with videos related to

Pageof 14
Sort By:
The New England Journal of Medicine|September 4, 1997
Low-molecular-weight heparinsJ I Weitz
Seminars in Hematology|December 14, 1999
Thrombosis and anticoagulationJ Hirsh, J I Weitz
The Journal of Clinical Investigation|July 1, 1990
Urokinase has direct catalytic activity against fibrinogen and renders it less clottable by thrombinJ I Weitz, B Leslie
Annual Review of Medicine|January 1, 1992
Antithrombins: their potential as antithrombotic agentsJ I Weitz, J Hirsh
Lancet (London, England)|May 5, 1999
New antithrombotic agentsJ Hirsh, J I Weitz
Chest|February 7, 2001
New anticoagulant drugsJ I Weitz, J Hirsh
Chest|November 20, 1998
New antithrombotic agentsJ I Weitz, J Hirsh
The American Journal of Cardiology|November 11, 1998
Direct thrombin inhibitors for treatment of arterial thrombosis: potential differences between bivalirudin and hirudinS M Bates, J I Weitz
Archives of Internal Medicine|March 29, 2000
Beyond heparin and aspirin: new treatments for unstable angina and non-Q-wave myocardial infarctionJ I Weitz, S M Bates
Cardiovascular Research|May 26, 1999
Prevention of activation of blood coagulation during acute coronary ischemic syndromes: beyond aspirin and heparinS M Bates, J I Weitz
Pageof 14

Showing results (11-20 of 136) with videos related to

Sort By:
Pageof 14
The New England Journal of Medicine|September 4, 1997
Low-molecular-weight heparinsJ I Weitz
Seminars in Hematology|December 14, 1999
Thrombosis and anticoagulationJ Hirsh, J I Weitz
The Journal of Clinical Investigation|July 1, 1990
Urokinase has direct catalytic activity against fibrinogen and renders it less clottable by thrombinJ I Weitz, B Leslie
Annual Review of Medicine|January 1, 1992
Antithrombins: their potential as antithrombotic agentsJ I Weitz, J Hirsh
Lancet (London, England)|May 5, 1999
New antithrombotic agentsJ Hirsh, J I Weitz
Chest|February 7, 2001
New anticoagulant drugsJ I Weitz, J Hirsh
Chest|November 20, 1998
New antithrombotic agentsJ I Weitz, J Hirsh
The American Journal of Cardiology|November 11, 1998
Direct thrombin inhibitors for treatment of arterial thrombosis: potential differences between bivalirudin and hirudinS M Bates, J I Weitz
Archives of Internal Medicine|March 29, 2000
Beyond heparin and aspirin: new treatments for unstable angina and non-Q-wave myocardial infarctionJ I Weitz, S M Bates
Cardiovascular Research|May 26, 1999
Prevention of activation of blood coagulation during acute coronary ischemic syndromes: beyond aspirin and heparinS M Bates, J I Weitz
Pageof 14